PharmaSources.comOctober 22, 2020
Tag: Pharma Product Writer , PharmaSources.com , Chinese pharmaceutical industry
China is a growing market and Chinese pharmaceutical industry is estimated to reach $161.8 billion by 2023 and takes a 30% share globally. China is the world’s largest pharmaceutical ingredients producer. APIs take up 81% of its total pharmaceutical exports, with chemical APIs dominate the API market. Following the API exports are pharmaceutical preparations, finished drug products (11%, $4.1 billion over $37 billion), and biochemical drugs (8%, $2.7 billion over $37 billion).
According to researchers at GlobalData, Pharma sales increasingly rely on virtual platforms due to COVID-19. Among all the vertical platforms, online trade platforms have been ideal method for the pharmaceutical suppliers and buyers to match the perfect partners until reaching deals, which provides opportunities for the pharma freelance writers to create true value in the post-pandemic times with their expertise.
How to Become a Pharma Product Writer for PharmaSources.com
PharmaSources.com is a vertical and professional e-commerce marketplace serving the pharmaceutical industry for ten years. PharmaSources.com has more than 3200 registered suppliers, most of which are exhibitors of CPhI China.
PharmaSources.com is also the initiator of the original writer league in the pharmaceutical industry. Upgraded from the former website En-CPhI.CN, the platform provides users with professional reviews on top pharmaceutical products, in-depth trend analysis into various categories in a range, helping the buyers make decisions while procuring products online and achieving a business increase in the pharmaceutical industry.
Why join us? For analysts, managers, or anyone who is already an expert in the product field, becoming a product writer on PharmaSources.com allows you to reach the right audience in the right marketplace where the pharmaceutical deals happen. It is also a good method for the writers to acquire the traffic you deserve and even for the salesperson to reach potential customers.
All you need to do is:
Email to Julia.zhang@imsinoexpo.com
CV and sample works are necessary to be included in the email
What we can provide:
Satisfying rates
An opportunity to become KOL in the pharmaceutical industry
Link to Omnimedia platform
Articles will be published on Product Guide
Requirements for writers and articles:
Work as a freelance writer
Above 70% of originality
No less than 800 words per article
First release and exclusive rights for PharmaSources.com
If you are confident that you can meet or even beyond all the requirements above, join us to be the best product writer who could provide real help with your readers in a post-pandemic era!
About PharmaSources.com (www.PharmaSources.com)
PharmaSources.com, as a vertical e-commerce online marketplace serving the pharmaceutical industry, is now upgraded from CPhI.CN (www.en-cphi.cn) after its 10 years’ developing in the industry. It is dedicated to providing information on high-quality products and suppliers for global customers and delivering services to over 90,000 active members across 211 countries and regions, featuring over 1,600,000 products in 30 major categories spanning the entire pharma supply chain. Our mission is to connect global buyers with quality suppliers and facilitate easy trade of the pharmaceutical industry.
References:
1. https://www.americanactionforum.org/print/?url=https://www.americanactionforum.org/insight/u-s-dependence-on-chinese-pharmaceuticals-overstated/
2. China’s Pharmaceutical Industry
https://daxueconsulting.com/pharmaceutical-industry-china/
3. The API industry in China: Producing and exporting to the global market
https://daxueconsulting.com/api-industry-in-china/
4. Pharma sales to increasingly rely on virtual platforms due to COVID-19, says report https://www.europeanpharmaceuticalreview.com/news/116487/pharma-sales-to-increasingly-rely-on-virtual-platforms-due-to-covid-19-says-report/
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: